KP1019(FFC14A)|KP-1019|ruthenium anticancer agent

KP1019(FFC14A)|KP-1019|ruthenium anticancer agent

KP1019 (FFC14A) is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clinical trials.

Product Name: KP1019(FFC14A)|Cat No. DC9788|CAS: 124875-20-3|Other names:KP1019; KP 1019; KP1019; FFC14A; indazolium

KP1019, also known as FFC14A, is just the second ruthenium-based anticancer agent after NAMI-A which was developed to the stage of clinical trials. Important steps